An Act To Ensure That Rebates From Prescription Drug Manufacturers Are Passed On To Patients At Pharmacies
LD 1053 requires pharmacy benefit managers (PBMs) and insurance carriers in Maine to pass prescription drug rebates directly to patients at the pharmacy counter, reducing their out-of-pocket costs for specific medications. This law replaces a previous provision that allowed rebates to be retained by insurers instead of reaching patients. PBMs and carriers must annually report compliance to the Insurance Superintendent, who can impose civil penalties for noncompliance. The bill directly affects patients filling prescriptions in Maine and the entities managing drug coverage (PBMs and insurers). It ensures rebates from drug manufacturers serve to lower patient costs, not offset insurer premiums.
Bill status
failed
1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
Governor
Introduced Mar 12, 2025
Last action Apr 17, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
7
Key actions
1
Committee
2
Apr 16, 2025
Legislature · Passed
Reported Out - ONTP
legislature
Mar 12, 2025
Committee
The Bill was REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES pursuant to Joint Rule 308.2 and ordered printed pursuant to Joint Rule 401.
lower
1 primary · 9 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about LD 1053
Scope: ME
Hi! I can help you understand LD 1053. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline